IRIS
VINCENZI, BRUNO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 18.472
NA - Nord America 4.120
EU - Europa 1.928
SA - Sud America 987
AF - Africa 112
OC - Oceania 54
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 25.675
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 13.537
US - Stati Uniti d'America 3.910
CN - Cina 2.193
HK - Hong Kong 1.810
BR - Brasile 734
GB - Regno Unito 581
IT - Italia 543
VN - Vietnam 473
DE - Germania 226
IN - India 134
CA - Canada 120
NL - Olanda 119
AR - Argentina 116
FI - Finlandia 65
MX - Messico 65
ZA - Sudafrica 62
JP - Giappone 59
ID - Indonesia 58
UA - Ucraina 54
AU - Australia 49
PL - Polonia 48
TR - Turchia 48
ES - Italia 37
FR - Francia 37
EC - Ecuador 33
BD - Bangladesh 28
SE - Svezia 28
RU - Federazione Russa 26
EE - Estonia 24
CZ - Repubblica Ceca 23
CO - Colombia 22
PY - Paraguay 22
CH - Svizzera 19
CL - Cile 19
AT - Austria 17
PE - Perù 17
BE - Belgio 15
UZ - Uzbekistan 14
LT - Lituania 13
SA - Arabia Saudita 13
TW - Taiwan 13
KR - Corea 11
VE - Venezuela 11
EG - Egitto 9
IR - Iran 8
SI - Slovenia 8
UY - Uruguay 8
IQ - Iraq 7
PH - Filippine 7
RO - Romania 7
AZ - Azerbaigian 6
IL - Israele 6
PT - Portogallo 6
AM - Armenia 5
MA - Marocco 5
PK - Pakistan 5
TH - Thailandia 5
DM - Dominica 4
DZ - Algeria 4
GT - Guatemala 4
KE - Kenya 4
AE - Emirati Arabi Uniti 3
BF - Burkina Faso 3
BG - Bulgaria 3
CY - Cipro 3
DO - Repubblica Dominicana 3
IE - Irlanda 3
LV - Lettonia 3
ML - Mali 3
NP - Nepal 3
NZ - Nuova Zelanda 3
RS - Serbia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
FK - Isole Falkland (Malvinas) 2
GH - Ghana 2
GR - Grecia 2
HN - Honduras 2
HT - Haiti 2
HU - Ungheria 2
JO - Giordania 2
LB - Libano 2
LU - Lussemburgo 2
NE - Niger 2
NG - Nigeria 2
NI - Nicaragua 2
OM - Oman 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SR - Suriname 2
TJ - Tagikistan 2
TL - Timor Orientale 2
YE - Yemen 2
AQ - Antartide 1
BB - Barbados 1
BJ - Benin 1
Totale 25.643
Salva come PNG Salva come JPEG
Città #
Hong Kong 1.783
Singapore 1.481
Hefei 1.086
Ashburn 978
Boardman 657
London 507
Dallas 440
Beijing 374
Shanghai 354
Ho Chi Minh City 173
Los Angeles 151
Council Bluffs 123
San Francisco 123
Hanoi 102
Munich 101
Rome 100
São Paulo 82
Amsterdam 79
Pune 77
Toronto 72
Seattle 68
Santa Clara 59
New York 58
Washington 54
Warsaw 46
Tokyo 40
Turku 40
Milan 38
Johannesburg 37
Mexico City 33
Brooklyn 32
Chicago 29
Rio de Janeiro 28
Boston 25
Helsinki 25
Melbourne 24
Stockholm 24
Chennai 23
Montreal 22
Brno 20
Da Nang 20
Biên Hòa 19
Secaucus 19
St Louis 17
Haiphong 16
Buenos Aires 15
Ankara 14
The Dalles 14
Charlotte 13
Sydney 13
Thái Bình 13
Asunción 12
Canberra 12
Central 12
Hasselt 12
Naples 12
West Jordan 12
Curitiba 11
Denver 11
Lima 11
Phoenix 11
Quito 11
Belo Horizonte 10
Porto Alegre 10
Tashkent 10
Atlanta 9
Bologna 9
Brasília 9
Frankfurt am Main 9
Guangzhou 9
Hanover 9
Ninh Bình 9
Palermo 9
Turin 9
Hải Dương 8
Manchester 8
Modena 8
New Delhi 8
Riyadh 8
Sona 8
Vienna 8
Fortaleza 7
Guayaquil 7
Haikou 7
Jinan 7
Osasco 7
Poplar 7
Ribeirão Preto 7
Boydton 6
Bắc Giang 6
Campinas 6
Campobasso 6
Caxias do Sul 6
Duque de Caxias 6
Ha Long 6
Hortolândia 6
Jakarta 6
Manaus 6
Mong Kok 6
Mumbai 6
Totale 10.156
Salva come PNG Salva come JPEG
Nome #
Aspetti etico-clinici del percorso decisionale ed assistenziale per la sedazione palliativa 306
1065P Dose dependent detrimental effect of baseline pantoprazole on clinical outcomes from first-line chemo-ICI regimens in patients with advanced stage NSCLC 251
A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: An open-label, non randomized, pilot study 232
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss 229
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 220
A novel predictive biomarker of immunotherapy response in metastatic renal cell carcinoma (mRCC): The lymphocyte microRNA expression profile. 218
Cardiotossicità da antracicline 217
ANGIOGENESIS AND ONCOGENES IN COLON CANCER 213
Doctor-patient communication tricks. Ontological study a Campus Bio-Medico University of Rome 212
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 212
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 211
COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables 209
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung) 207
96P Induction chemotherapy backbone in frail patients (pts) with advanced NSCLC treated with chemotherapy plus pembrolizumab (P): A single institution retrospective audit of dose intensities from modified regimens 202
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 200
Sarcopenia Does Not Impact the Outcome of Patients with Multiple Myeloma Consolidated with Autologous Hematopoietic Stem Cell Transplantation 198
Artificial Intelligence in Detection, Management, and Prognosis of Bone Metastasis: A Systematic Review 198
Premetastatic niche: ready for new therapeutic interventions? 197
Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients 197
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features 196
Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions 196
Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma 192
Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial 191
Activity of chemotherapy in inflammatory myofibroblastic tumor (IMT): A retrospective analysis within the Italian Rare Tumours Network (RTR). 189
Enoxiparin effects depend on body-weight and current doses my be inadequate in obese patients 187
Early opioid exposure (EOE) and impaired efficacy in patients with advanced NSCLC treated with PD-L1 inhibition: A pooled post hoc analysis of the POPLAR and OAK trials 186
Prevention of radiotherapy-induced emesis 186
Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients 185
COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters 185
Urinary complications from breast cancer metastasis: case report and review of the literature 185
Bisphosphonates: new antiangiogenic molecules in cancer treatment? 184
Che-1/AATF-induced transcriptionally active chromatin promotes cell proliferation in multiple myeloma 183
Survey on learning needs and preferred sources of information to meet these needs in Italian oncology patients receiving chemotherapy 183
Complications of therapy in cancer patients: Case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient 181
A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma 180
Gemcitabine-induced atrial fibrillation: A hitherto unreported manifestation of drug toxicity 179
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients 179
Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities 176
A staphylococcus aureus coinfection on a COVID-19 pneumonia in a breast cancer patient 174
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 174
CD133 and ABCB5 as stem cell markers on sentinel lymph node from melanoma patients 173
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 173
Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging 171
Docetaxel induced pericardial effusion 167
Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients 157
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients 142
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 128
Liver harvesting surgical technique for the treatment of retro-hepatic caval thrombosis concomitant to renal cell carcinoma: perioperative and long-term results in 15 patients without mortality 128
A giant sarcoma of the parotid gland: A case report and review of the literature 121
'Internal bracing' surgery in the management of solid tumor metastases of the thoracic and lumbar spine 117
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 116
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome 111
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 110
Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect 110
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 108
An international survey on the use of guidelines for palliative sedation therapy 107
'Old' and 'new' drugs for the treatment of cancer pain 107
Circulating endothelial cell (CEC) kinetic in patients with Multiple Myeloma (MM) who receive Au-HSCT (Autologous Hematopoietic Stem Cell Transplantation) 104
Carcinoma of the Ampulla of Vater morphological and immunophenotypical classification predicts overall survival 102
Biological effects of cabozantinib on bone microenvironment 102
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients 100
Activity of sirolimus in advanced epithelioid hemangioendothelioma (EHE): A retrospective analysis within the Italian Rare Tumor Network (RTR). 99
Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review 97
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin 97
Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients 96
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours 96
Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma 96
How I Treat Localized Soft Tissue Sarcomas: Update on Diagnosis, Risk Stratification, and Treatment 95
Adenogenesis Factors FGF7, FGF10, FGF23, IFN-τ and HGF in Endometriosis Tissue Respect to Eutopic Endometrium: An Immunohistochemical Study 95
An increase of CA 19.9 as the first clinical sign of ileocecal valve metastasis from breast cancer 95
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 95
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 95
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 95
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 95
Idiosyncratic reaction after oxaliplatin infusion 94
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 94
Azygo-tracheal fistula in a complete implantable central venous system 94
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 94
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 93
In vivo effects of zoledronic acid on peripheral gamma delta T lymphocytes in early breast cancer patients 93
Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial 93
Infusion of bevacizumab increases the risk of intestinal perforation: results on a series of 143 patients consecutively treated 93
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 93
Cardiotoxicity of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Pathophysiology, Clinical Implications, and Echocardiographic Assessment 92
Locally recurrent extraskeletal myxoid chondrosarcoma of the shoulder: a case of complete neoadjuvant radiotherapy response 92
Atypical chronic head and neck pain: don't forget Eagle's syndrome 92
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 91
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 90
Cox-2 Expression in Different Histotypes of Ampullary Carcinoma 89
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 88
Persisting perianal ulcer after radiotherapy for anal cancer: recurrence of disease or late radiation-related complication? 87
A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl) 82
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes 82
A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients 82
LIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE 79
Fatal thrombocytopenia and thrombocytopathia: An unusual onset of non small cell lung cancer 79
Italian translation of the Manchester-Oxford Foot Questionnaire (MOXFQ), with re-assessment of reliability and validity 77
Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients 75
Classic Kaposi Sarcoma: to treat or not to treat? 72
Pamidronate induces modifications of circulating angiogenetic factors in cancer patients 69
Totale 14.159
Salva come PNG Salva come JPEG
Categoria #
all - tutte 231.229
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 231.229
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022753 0 9 12 4 49 12 10 9 24 23 26 575
2022/2023194 23 7 3 14 7 8 19 15 15 7 69 7
2023/20241.888 49 213 155 165 156 766 27 113 27 53 81 83
2024/202517.397 277 217 719 138 146 420 296 76 1.521 1.321 5.821 6.445
2025/20265.619 1.506 684 1.068 1.806 555 0 0 0 0 0 0 0
Totale 25.851